Skip to content

Feasibility study of group unified protocol psychotherapy for patients with depressive and anxiety disorders

Feasibility study of group unified protocol psychotherapy for patients with depressive and anxiety disorders - Pilot study of group unified protocol for anxiety and depression (GUPPY Study)

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000023632
Enrollment
24
Registered
2016-08-17
Start date
2016-08-24
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unipolar mood disorders, Anxiety disorders

Interventions

Group cognitive behavioral therapy (Unified Protocol)

Sponsors

National Center of Neurology and Psychiatry
Lead Sponsor
Keio University School of Medicine Nishimura clinic
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Subjects with current DSM-IV Panic disorder with/without Agoraphobia, Agoraphobia without history of Panic Disorder, Specific Phobia, Social Phobia (Social Anxiety Disorder), Obsessive-Compulsive Disorder, Post-Traumatic Stress Disorder, Generalized Anxiety Disorder, Major Depressive Disorder, Dysthymic disorder 2. The Clinical Global Impressions Scale-Severity of illness >= 4 3. Age 20 years or older, and 65 years or younger at screening 4. Subjects who give full consent in the participation of the study

Exclusion criteria

Exclusion criteria: 1. No alcohol or substance use disorder in a year prior to the baseline 2. No manic episode or psychotic disorders at baseline 3. No serious suicidal ideation at baseline (GRID-HAMD Item 3 symptom intensity is less than moderate) 4. Evidence of unable to participate half or more of the intervention phase 5. No structured psychotherapy (except supportive therapy) during the intervention 6. No major cognitive deficits or No life-threatening, severe or unstable physical disorders at baseline 7. Other relevant reason decided by the investigators

Design outcomes

Primary

MeasureTime frame
1.The Clinical Global Impressions Scale-Severity(CGI-S) 2.Objective severity of depressive symptoms(GRID-HAMD)

Secondary

MeasureTime frame
1. The Clinical Global Impressions Scale- Improvement(CGI-I) 2. Subjective severity of Anxiety and impairment(OASIS) 3. Subjective severity of Depression and impairment(ODSIS) 4. Quality of life(EQ-5D-5L) 5. Function(SDISS/GAF) 6. Emotion Regulation(ERSQ) 7. Neuroticism(EPQR-S) 8. Subjective symptoms for primary diagnosis 9. Drop Out rate 10. Adverse Event

Countries

Japan

Contacts

Public ContactNoriko Kato

National Center of Neurology and Psychiatry National Center for Cognitive Behavior Therapy and Research

norikokato@ncnp.go.jp042-341-2711

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026